If you live with Crohn’s disease or ulcerative colitis, you have probably experienced the frustration of a flare that seemed to appear without warning. Understanding what might provoke increased symptoms, and learning how to track your own patterns, can help you make more informed decisions and communicate more effectively with your clinical team.
What is an IBD flare?
A flare refers to a period when symptoms of inflammatory bowel disease (IBD) become more active or severe. This may include increased bowel frequency, abdominal pain, rectal bleeding, fatigue, and urgency. It is important to recognise that symptoms do not always reflect the degree of inflammation in the gut. Some people experience significant symptoms with mild inflammation, while others may have active disease with fewer noticeable symptoms. This is why clinical assessment, including blood tests, stool samples, and sometimes endoscopy, remains essential for monitoring disease activity.
Why flares happen
Flares can occur even when you are doing everything right. IBD is a chronic condition driven by an inappropriate immune response in the gut, and many factors can influence immune activity and gut inflammation. The interplay between genetics, the immune system, the gut microbiome, and environmental factors means that no two people with IBD will respond identically to the same trigger.
Common flare triggers
Understanding the most frequently reported triggers can help you begin to identify patterns in your own experience.
Stress and sleep disruption
Psychological stress and poor sleep quality are among the most commonly reported flare triggers. Stress activates the hypothalamic-pituitary-adrenal (HPA) axis, a system that regulates immune responses and gut function. Chronic stress can alter gut permeability, disrupt gut bacteria balance, and increase pro-inflammatory signalling molecules. Sleep deprivation has similar effects, impairing immune regulation and increasing systemic inflammation. While stress does not cause IBD, it can influence disease activity in people who already have the condition.
Infections and immune activation
Gastroenteritis or respiratory infections can trigger flares in some people with IBD. When the immune system is activated to fight an infection, it can inadvertently increase inflammation in the gut. This is particularly relevant in IBD, where the immune system is already primed to overreact. Antibiotics, often used to treat infections, can also disrupt the gut microbiome and contribute to symptom worsening in some individuals.
Non-steroidal anti-inflammatory drugs
Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen are known to increase the risk of flares in people with IBD. These medications inhibit the production of prostaglandins, which help protect the gut lining. Without this protective effect, the intestinal barrier becomes more vulnerable to damage and inflammation. Paracetamol is generally considered a safer alternative for pain relief, though it is always worth discussing options with your doctor.
Dietary factors
Diet is one of the most variable and individualised aspects of flare management. High-fat meals, particularly those rich in saturated fats, may increase gut permeability and promote inflammatory signalling. Artificial additives such as emulsifiers and sweeteners have been shown in some studies to alter the gut microbiome and increase inflammation. Alcohol and caffeine can irritate the gut lining and increase bowel motility. Fibre is more complex: insoluble fibre can be difficult to tolerate during active inflammation, but soluble fibre may support gut health in remission. Food intolerances, such as lactose intolerance, are more common in people with IBD and can mimic or worsen symptoms.
Smoking and vaping
Smoking has a paradoxical effect in IBD. In Crohn’s disease, smoking is strongly associated with increased flare risk, more severe disease, and a higher need for surgery. In ulcerative colitis, smoking appears to have a protective effect during active disease, though it increases the risk of other serious health conditions and is not recommended as a treatment strategy. The mechanisms are not fully understood but may relate to nicotine’s effects on immune signalling and gut motility. Vaping has not been studied as extensively, but early evidence suggests it may also influence gut inflammation and microbiome composition.
Missed or inconsistent medication
One of the most preventable flare triggers is inconsistent use of maintenance medication. Many IBD therapies work by suppressing the underlying immune activity that drives inflammation. Stopping or reducing medication during remission can allow inflammation to re-emerge, even before symptoms become noticeable. If you are finding it difficult to take your medication as prescribed, speak with your IBD team about alternative formulations, dosing schedules, or therapies that are easier to manage.
How to identify your triggers
Tracking your symptoms, exposures, and well-being over time is one of the most practical ways to identify patterns. A symptom diary should include: daily bowel frequency and stool consistency, abdominal pain or discomfort, fatigue and sleep quality, foods and meals consumed, stressful events or periods, illness or medication changes, and menstrual cycle if relevant. Over weeks and months, patterns may begin to emerge. You may notice that flares tend to follow high-stress periods, certain meals, or disrupted sleep. Share this information with your gastroenterologist or dietitian. They can help interpret the patterns and distinguish between true triggers and coincidental associations.
When symptoms do not mean a flare
Not all symptom increases represent active inflammation. Irritable bowel syndrome (IBS) type symptoms are common in people with IBD, even during remission. Stress, dietary changes, and gut motility issues can all cause discomfort without increasing disease activity. This is why objective measures such as faecal calprotectin, C-reactive protein (CRP), and endoscopy are used alongside symptom reporting to assess true disease activity.
Practical takeaways
- Keep a simple symptom and exposure diary to help identify patterns over time.
- Prioritise consistent sleep and explore stress management strategies such as mindfulness, physical activity, or talking therapy.
- Avoid NSAIDs unless specifically advised by your doctor, and discuss safer pain relief options.
- Take your maintenance medication as prescribed, even when you feel well.
- If you suspect a food trigger, work with a registered dietitian to test it systematically rather than restricting your diet unnecessarily.
- Report any pattern you notice to your IBD team so they can help you interpret it in the context of your overall disease activity.
When a flare needs urgent attention
Most flares can be managed through your usual IBD team in the normal course of things, but some symptoms need same-day assessment rather than watchful waiting. Contact your IBD team urgently, or seek emergency care if you cannot reach them, if you develop heavy or persistent rectal bleeding, severe or worsening abdominal pain, a high temperature, persistent vomiting or inability to keep fluids down, a swollen and tender abdomen, or signs of dehydration such as dizziness, minimal urine output or confusion. Frequent bloody diarrhoea combined with fever and a rapid heartbeat also warrants prompt assessment. These can indicate a severe flare or a complication that needs treatment in hospital, and identifying your triggers is not the priority in that situation.
Conclusion
Flares are a frustrating reality of living with IBD, but understanding common triggers and tracking your own responses can help you feel more in control. Some triggers, such as stress, sleep, and medication adherence, can be managed with practical strategies. Others, such as infections or changes in disease activity, may be harder to predict. The goal is not perfection, but awareness and collaboration with your clinical team to support long-term stability and reduce inflammatory load over time.
References
- Bernstein CN, Singh S, Graff LA, et al. A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol. 2010;105(9):1994-2002. doi:10.1038/ajg.2010.140
- Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut. 2005;54(10):1481-1491. doi:10.1136/gut.2005.064261
- Ananthakrishnan AN, Khalili H, Pan A, et al. Association between depressive symptoms and incidence of Crohn’s disease and ulcerative colitis: results from the Nurses’ Health Study. Clin Gastroenterol Hepatol. 2013;11(1):57-62. doi:10.1016/j.cgh.2012.08.032
- Felder JB, Korelitz BI, Rajapakse R, et al. Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study. Am J Gastroenterol. 2000;95(8):1949-1954. doi:10.1111/j.1572-0241.2000.02262.x
- Opstelten JL, Plassais J, van Mil SW, et al. Gut microbial diversity is reduced in smokers with Crohn’s disease. Inflamm Bowel Dis. 2016;22(9):2070-2077. doi:10.1097/MIB.0000000000000852
- Chassaing B, Koren O, Goodrich JK, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015;519(7541):92-96. doi:10.1038/nature14232
- Gracie DJ, Williams CJ, Sood R, et al. Negative effects on psychological health and quality of life of genuine irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2017;15(3):376-384. doi:10.1016/j.cgh.2016.05.012
- Ali T, Yun L, Rubin DT. Risk of post-operative complications associated with anti-TNF therapy in inflammatory bowel disease. World J Gastroenterol. 2012;18(3):197-204. doi:10.3748/wjg.v18.i3.197
This article is intended for informational and educational purposes only. It does not constitute medical advice and should not be used as a substitute for professional medical guidance, diagnosis, or treatment.